Cablivi
Active substance: caplacizumab
KIT · caplacizumab
United StatesActive
Marketing holder: Genzyme Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-4c93-7718-95c2-5ede23b010dd;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 58468-0225
- Registration status
- Active
- Dispensing
- Prescription only
Sources
- product · openFDA NDC · 58468-0225 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 58468-0225 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 58468-0225 · Verified 2026-10-09 · open in source